Roger E. Markwell

1.5k citations

42 papers · 1.1k indexed · h-index 18

Organic Chemistry top 5%
- Synthetic Organic Chemistry Methods 6
- Synthesis and Reactivity of Heterocycles 3
Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases 3
Pharmaceutical Science top 5%
Physiology top 10%
- Alzheimer's disease research and treatments 7
Computational Theory and Mathematics top 5%
- Computational Drug Discovery Methods 3
Oncology
- Peptidase Inhibition and Analysis 6
Cancer Research
- Protease and Inhibitor Mechanisms 5
Pharmacy
- Oral and gingival health research 4

Co-authors: David Howlett Ashley R. George Davina E. OWEN Robin V. Ward Harry Wadsworth K.H. Jennings Jane E. SWATTON Stephen Wood
Cited by: Organic Chemistry Pharmacology Pharmaceutical Science
Journals: Bioorganic & Medicinal Chemistry Letters (9 papers)Journal of the Chemical Society Perkin Transactions 1 (7 papers)Biochemical Journal (6 papers)
Partner nations: United Kingdom United States Spain

In The Last Decade

Roger E. Markwell

37 papers receiving 1.0k citations

Peers

Countries citing papers authored by Roger E. Markwell

Since Specialization

Citations

This map shows the geographic impact of Roger E. Markwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger E. Markwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger E. Markwell more than expected).

Fields of papers citing papers by Roger E. Markwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger E. Markwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger E. Markwell. The network helps show where Roger E. Markwell may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Roger E. Markwell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roger E. Markwell Line = papers co-authored together Roger E. Markwell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases Bioorganic & Medicinal Chemistry Letters ·Timothy J. Miles,Alan J. Hennessy,B.D. Bax,Gerald Brooks,Barry S. Brown,Pamela Brown,Siegfried Bethke,Синельников Альберт Геннадьевич,Steven Dabbs,David T. Davies,S.D. Cooke,Ilaria Giordano,Jennifer L. Hoover,Graham E. Jones,Magri Junior,Roger E. Markwell,Elisabeth A. Minthorn,A. M. Obimakinde,Michael N. Gwynn,Neil D. Pearson	2016	33
2	Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases Bioorganic & Medicinal Chemistry Letters ·Timothy J. Miles,Kosrat ezaddin Omar,Gerald Brooks,Pamela Brown,Синельников Альберт Геннадьевич,Steven Dabbs,David T. Davies,David L. Downie,Susanne Eyrisch,Ilaria Giordano,Michael N. Gwynn,Alan J. Hennessy,Jennifer L. Hoover,Jianzhong Huang,Graham E. Jones,Roger E. Markwell,Stephen Rittenhouse,Hong Xiang,Neil D. Pearson	2011	33
3	Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells Biochemical Journal ·Charles E. Jahren,Stephen J. Assinder,Gary Christie,Grant Mason,Roger E. Markwell,Harry Wadsworth,Mark R. McLaughlin,Florian Ramousse,Marie Chabot‐Fletcher,John Breton,David Allsop,A. Jennifer Rivett	2000	43
4	Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells Biochemical Journal ·Charles E. Jahren,Stephen J. Assinder,Gary Christie,Grant Mason,Roger E. Markwell,Harry Wadsworth,Mark R. McLaughlin,Florian Ramousse,Marie Chabot‐Fletcher,John Breton,David Allsop,A. Jennifer Rivett	2000	7
5	Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation. PubMed ·David Howlett,Ashley R. George,Davina E. OWEN,Robin V. Ward,Roger E. Markwell	1999	114
6	β-, γ- and δ-Lactams as conformational constraints in ring-closing metathesis Journal of the Chemical Society Perkin Transactions 1 ·Chris A. Tarling,Andrew B. Holmes,Roger E. Markwell,Neil D. Pearson	1999	41
7	Inhibition of fibril formation in β-amyloid peptide by a novel series of benzofurans Biochemical Journal ·David Howlett,Amanda Perry,A.R. Ulmaskulov,Jane E. SWATTON,K.H. Jennings,Claus Spitzfaden,Harry Wadsworth,Stephen Wood,Roger E. Markwell	1999	100
8	Studies on inhibition of β-amyloid formation in APP-751-transfected IMR-32 cells, and SPA4CT-transfected SHSY5Y cells Lancaster EPrints (Lancaster University) ·David Allsop,G.S. Christie,Chi Cheung Poon,Sandra L. Holmes,Roger E. Markwell,David Owen,Layton H. Smith,Harry Wadsworth,Robin V. Ward,Tobias Hartmann,Stefan F. Lichtenthaler,Geneviève Evin,Steve Fuller,Judith Tanner,Colin L. Masters,Konrad Beyreuther,Nurizzati Hidayah Mohd Afendi	1997	2
9	Novel 2,5-disubstituted-1H-pyrroles with high affinity for the dopamine D3 receptor Bioorganic & Medicinal Chemistry Letters ·Magdalena Real,Izzy Boyfield,Martyn C. Coldwell,Michael S. Hadley,Sara Twohill,Christopher N. Johnson,Roger E. Markwell,David J. Nash,Graham J. Riley,Geoffrey Stemp,Harry J. Wadsworth	1996	10
10	588 Studies on inhibition of βA4 formation in APP-751 transfected IMR-32 cells, and SPA4CT transfected SHSYSY cells Neurobiology of Aging ·David Allsop,G.S. Christie,Chi Cheung Poon,Sandra L. Holmes,Roger E. Markwell,David Owen,Layton H. Smith,Harry Wadsworth,Robin V. Ward,Tobias Hartmann,Stefan F. Lichtenthaler,Geneviève Evin,Steve Fuller,Colin L. Masters,Konrad Beyreuther,Nurizzati Hidayah Mohd Afendi	1996	0
11	A simplein vivo model of collagen degradation using collagen-gelled cotton buds: The effects of collagenase inhibitors and other agents Inflammation Research ·Eric Karran,Dylan Dittrich-Reed,Remi Castioni,Roger E. Markwell,Gregory P. Harper	1995	4
12	In vivo model of cartilage degradation–effects of a matrix metalloproteinase inhibitor. Annals of the Rheumatic Diseases ·Eric Karran,Tim Young,Roger E. Markwell,Gregory P. Harper	1995	20
13	Inhibitors of human collagenase: dipeptide mimetics with lactam and azalactam moieties at the position Bioorganic & Medicinal Chemistry Letters ·John Bird,Gregory P. Harper,Ian Hughes,David J. Hunter,Eric Karran,Roger E. Markwell,C. Wrutniak-Cabello,Shahzad S. Rahman,Robert W. Ward	1995	5
14	Synthesis of novel N-phosphonoalkyl dipeptide inhibitors of human collagenase Journal of Medicinal Chemistry ·John Bird,Keerthi Thamotharampillai,Gregory P. Harper,David J. Hunter,Eric Karran,Roger E. Markwell,C. Wrutniak-Cabello,Shahzad S. Rahman,Robert W. Ward	1994	123
15	Synthesis of novel modified dipeptide inhibitors of human collagenase: .beta.-mercapto carboxylic acid derivatives Journal of Medicinal Chemistry ·V. Bytchkov,John Bird,Laramie M. Gaster,Gregory P. Harper,Ian Hughes,Eric Karran,Roger E. Markwell,C. Wrutniak-Cabello,A Mariuzza Roy	1993	32
16	Novel 1H-benzimidazol-4-ols with potent 5-lipoxygenase inhibitory activity Journal of Medicinal Chemistry ·Derek R. Buckle,Keith Foster,John F. Taylor,J. M. Tedder,Tony R. Nsanganira,Christèle Gras Le Guen,José Luis Bermúdez,Roger E. Markwell,A Mariuzza Roy	1987	16
17	Reactions of diterpenoids in concentrated sulphuric acid. Part 1. Novel rearrangements of tetrahydroabietic acids Journal of the Chemical Society Perkin Transactions 1 ·錬太郎長野,Rimvydė Lukšytė,Roger E. Markwell	1979	0
18	The synthesis and oxidation of N-hydroxy-derivatives of the β-adrenoceptor antagonists bufuralol and toliprolol Journal of the Chemical Society Perkin Transactions 1 ·Steven R. Jordan,Roger E. Markwell,Helen S. Forth	1978	6
19	Rearrangements of the gibbane skeleton during dehydrogenations with 2,3-dichloro-5,6-dicyanobenzoquinone Journal of the Chemical Society Chemical Communications ·B. E. Cross,Roger E. Markwell	1972	1
20	New metabolites of Gibberella fujikuroi. Part XVIII. 4bβ,7-Dihydroxy-1-methyl-8-methylenegibba-1,3,4a(10a)-trien-10-one Journal of the Chemical Society C Organic ·B. E. Cross,Roger E. Markwell	1971	2

About Roger E. Markwell

Roger E. Markwell is a scholar working on Pharmacy, Organic Chemistry, Cancer Research, Molecular Medicine and Physiology, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Peptidase Inhibition and Analysis (6 papers), Synthetic Organic Chemistry Methods (6 papers), Protease and Inhibitor Mechanisms (5 papers), Oral and gingival health research (4 papers), Synthesis and Reactivity of Heterocycles (3 papers), Computational Drug Discovery Methods (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). The work is most often cited by research in Organic Chemistry (439 citations), Pharmacology (244 citations), Pharmaceutical Science (83 citations), Physiology (316 citations) and Computational Theory and Mathematics (164 citations). Roger E. Markwell has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include David Howlett, Ashley R. George, Davina E. OWEN, Robin V. Ward, Harry Wadsworth, K.H. Jennings, Jane E. SWATTON, Stephen Wood, Claus Spitzfaden and Amanda Perry. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of the Chemical Society Perkin Transactions 1, Biochemical Journal, Journal of Medicinal Chemistry and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact